EP backs challenges to GMOs and active substances

by

The record of the EP backing the Environment Committee’s challenges to some active substances and GMOs continues unbroken.

On 10 March, the full Parliament backed the Committee  with clear majorities.

As they are implementing acts, the Commission will ignore the EP.

The constant trends on these file will become interesting when the ordinary legislation come up for revision.

On these votes, the EPP, ECR, Renew were severely  split under established voting lines.

 

EP Backs Environment Committee

Objection pursuant to Rule 112(2) and (3) on the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin

Implementing Act

Rapporteurs: Anja Hazekamp, Maria Arena, Tilly Metz

Vote in Committee: 24 February 2021

Vote: For 49, Against 29, Abstention 1  Link

Vote in Plenary: 10 March 2021

Vote for 472, Against 217, Abstentions 9

45

Objection pursuant to Rule 112(2) and (3) on the placing on the market of products containing, consisting of or produced from genetically modified cotton GHB614 × T304-40 × GHB119

Implementing Act

Rapporteurs: Martin Häusling, Günther Sidl, Anja Hazekamp, Sirpa Pietikäinen

Vote in Committee: 25 February 2021

Votes: For 53, Against 25, Abstention 1  Link

Vote in Plenary: 10 March 2021

Votes: For 491, Against 184, Abstentions 20

46

Objection pursuant to Rule 112(2) and (3) on the placing on the market of products containing, consisting of or produced from genetically modified maize MZIR098 (SYN-ØØØ98-3)

Implementing Act

Rapporteurs:Martin Häusling, Günther Sidl, Anja Hazekamp, Sirpa Pietikäinen

Vote in Committee: 25 February 2021
Vote: For 54, Against 25, Abstention 1  Link
Vote in Plenary: 10 March 2021
Votes: For 495, Against 181, Abstentions 18